Pre-market hot trades in the US stock market: Hyperscale Data pre-market down 9.31%; Ernexa Therapeutics pre-market down 8.52%

Tracking Unusual Activity
2025.10.30 08:52
portai
I'm PortAI, I can summarize articles.

Hyperscale Data pre-market down 9.31%; Ernexa Therapeutics pre-market down 8.52%; VCI Global pre-market up 107.22%; Cambium Networks pre-market up 89.15%; VivoSim Labs pre-market up 84.78%

Pre-market Hot Trades in US Stocks

Hyperscale Data, down 9.31% in pre-market trading, has no significant news recently. Trading is active with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Ernexa Therapeutics is down 8.52% in pre-market trading. Based on recent news,

  1. On October 29, Ernexa Therapeutics announced the research and development progress of its main cell therapy products ERNA-101 and ERNA-201. ERNA-101 aims to activate and regulate the immune system to recognize and attack cancer cells, while ERNA-201 targets inflammation and treats autoimmune diseases. Despite the company's progress in R&D, the market remains skeptical about the commercialization prospects of its products, leading to a decline in stock price.

  2. On October 29, the R&D progress of Ernexa Therapeutics' main products ERNA-101 and ERNA-201 failed to alleviate investors' concerns about its financial situation. The company focuses on developing ERNA-101 for the treatment of ovarian cancer, but the market is doubtful about its ability to successfully commercialize, further exacerbating the decline in stock price.

  3. On October 29, the R&D progress of Ernexa Therapeutics did not boost market confidence. Although the company has made some progress in the field of cell therapy, investors are concerned about its ability to achieve large-scale production and market promotion of its products, leading to a significant drop in stock price. The cell therapy industry is highly competitive, and the market is skeptical about the commercialization prospects of new products.

Top Gainers in Pre-market US Stocks

VCI Global is up 107.22% in pre-market trading. Based on recent news,

  1. On October 29, VCI Global announced that its subsidiary Smart Bridge Technologies Limited has been appointed as the exclusive issuer and financial manager of the XVIQ ecosystem. This appointment is expected to drive recurring revenue and long-term value creation in the AI, GPU, and real asset markets, boosting investor confidence and leading to a significant rise in stock price.

  2. On October 6, VCI Global released its financial report for the first half of the year, showing revenue of $18.7 million and earnings per share of $57.08. Despite a 99.82% decline in stock price year-to-date, the financial report data indicates strong profitability for the company, further driving the stock price increase.

  3. On October 30, VCI Global's stock price rose 87.78% in after-hours trading, closing at $3.38. Previously, the stock price had dropped 10% during regular trading hours, but the strong performance in after-hours trading indicates optimistic market expectations for the company's future development. The AI and GPU markets have been performing strongly recently, and investors are focusing on the long-term value in related fields Cambium Networks pre-market rose by 89.15%. Based on recent key news:

  4. On October 29, Cambium Networks announced integration with Starlink to provide enterprise-level service delivery. This collaboration has enhanced market expectations for the company's future growth potential, driving a significant increase in stock prices. Source: Cambium Networks announcement.

  5. On October 29, Cambium Networks launched the ONE Network platform, simplifying the management of its wired, wireless broadband, and network edge technologies. This innovation is seen as an important move to enhance the company's competitiveness, further boosting investor confidence. Source: Cambium Networks announcement. The trend of consolidation in the technology industry is evident, with a focus on innovation.

VivoSim Labs pre-market rose by 84.78%, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

Source: Tracking Unusual Activity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.